glyburide and vildagliptin

glyburide has been researched along with vildagliptin in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
El-Ouaghlidi, A; Foley, J; Holmes, D; Holst, JJ; Nauck, MA; Rehring, E; Schweizer, A1
Balez, S; Bullock, J; Dole, WP; He, YL; Jarugula, V; Ligueros-Saylan, M; Riviere, GJ; Schwartz, S; Serra, D; Wang, Y1
Casali, KR; Fofonka, A; Ribeiro, JP; Schaan, BD1
Berlanda, G; Bock, PM; Casali, KR; da Rosa, FM; da Silveira, AD; Fofonka, A; Schaan, BD1
Cesarino, CB; Cosenso-Martin, LN; Fernandes, LAB; Giollo-JĂșnior, LT; Machado, MN; Nakazone, MA; Vilela-Martin, JF; Yugar-Toledo, JC1
Chen, SH; Liu, XN; Peng, Y; Sun, QY1

Reviews

1 review(s) available for glyburide and vildagliptin

ArticleYear
Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta-analysis involving eight eligible randomized-controlled trials.
    Journal of cellular physiology, 2019, Volume: 234, Issue:3

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Exenatide; Female; Glyburide; Humans; Male; Metformin; Network Meta-Analysis; Pioglitazone; Randomized Controlled Trials as Topic; Rosiglitazone; Sulfonylurea Compounds; Vildagliptin

2019

Trials

5 trial(s) available for glyburide and vildagliptin

ArticleYear
The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:11

    Topics: Adamantane; Adult; Algorithms; C-Peptide; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glyburide; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Nitriles; Pyrrolidines; Vildagliptin

2007
Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes.
    International journal of clinical pharmacology and therapeutics, 2008, Volume: 46, Issue:7

    Topics: Adamantane; Adult; Aged; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Nitriles; Pioglitazone; Pyrrolidines; Thiazolidinediones; Vildagliptin

2008
Effects of vildagliptin compared with glibenclamide on glucose variability after a submaximal exercise test in patients with type 2 diabetes: study protocol for a randomized controlled trial, DIABEX VILDA.
    Trials, 2014, Nov-04, Volume: 15

    Topics: Adamantane; Biomarkers; Blood Glucose; Brazil; Clinical Protocols; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Endothelium, Vascular; Exercise Test; Glyburide; Glycated Hemoglobin; Hemodynamics; Humans; Hypoglycemic Agents; Nitriles; Oxidative Stress; Predictive Value of Tests; Prospective Studies; Pyrrolidines; Research Design; Time Factors; Treatment Outcome; Vildagliptin

2014
Impact of treatment with glibenclamide or vildagliptin on glucose variability after aerobic exercise in type 2 diabetes: A randomized controlled trial.
    Diabetes research and clinical practice, 2018, Volume: 143

    Topics: Adamantane; Aged; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exercise; Female; Glucose; Glyburide; Humans; Hypoglycemic Agents; Male; Middle Aged; Nitriles; Pyrrolidines; Vildagliptin

2018
Effect of vildagliptin versus glibenclamide on endothelial function and arterial stiffness in patients with type 2 diabetes and hypertension: a randomized controlled trial.
    Acta diabetologica, 2018, Volume: 55, Issue:12

    Topics: Adult; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Glyburide; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Pulse Wave Analysis; Vascular Stiffness; Vildagliptin

2018

Other Studies

2 other study(ies) available for glyburide and vildagliptin

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Vildagliptin monotherapy. To be avoided, like other DPP-4 inhibitors.
    Prescrire international, 2013, Volume: 22, Issue:138

    Topics: Adamantane; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glyburide; Humans; Hypoglycemic Agents; Metformin; Nitriles; Pyrrolidines; Vildagliptin

2013